Exponent(US:EXPO)2025-10-30 20:05Financial Performance - Total revenues for Q3 2025 increased by 8% to $147.1 million compared to $136.3 million in Q3 2024[4] - Net income rose to $28.0 million, or $0.55 per diluted share, in Q3 2025, up from $26.0 million, or $0.50 per diluted share, in Q3 2024[5] - EBITDA increased to $38.8 million, representing 28.3% of revenues before reimbursements, compared to $35.8 million, or 28.6%, in Q3 2024[6] - Year-to-date revenues for the first three quarters of 2025 grew by 3% to $434.6 million, compared to $421.7 million in the same period of 2024[7] - Net income for the quarter ended October 3, 2025, was $28,044,000, representing an increase of 7.7% compared to $26,044,000 for the same quarter in 2024[31] - EBITDA for the quarter ended October 3, 2025, was $38,837,000, up from $35,767,000 in the prior year, reflecting a growth of 5.8%[31] - EBITDAS for the nine months ended October 3, 2025, was $132,133,000, slightly down from $134,207,000 for the same period in 2024, a decrease of about 1.5%[31] Revenue Segmentation - The engineering and other scientific segment accounted for 84% of revenues before reimbursements in Q3 2025, with a 10% increase in this segment compared to the prior year[12] - The environmental and health segment represented 16% of revenues before reimbursements in Q3 2025, with a 9% increase driven by regulatory consulting in the chemicals industry[13] Future Guidance - Exponent plans to maintain revenue guidance while raising margin guidance for the full year 2025[14] - For the full fiscal year 2025, Exponent anticipates revenue growth in the low to mid-single digits and EBITDA to be between 26.0% to 27.0% of revenues before reimbursements[17] Dividend and Stock Repurchase - The company announced a quarterly cash dividend of $0.30 to be paid on December 19, 2025, and intends to continue paying quarterly dividends[10] - Exponent's Board of Directors approved an increase in the stock repurchase program by $100 million, in addition to $21.6 million available for repurchase as of October 3, 2025[11] Asset and Liability Changes - Total current assets decreased from $446,881,000 on January 3, 2025, to $416,786,000 on October 3, 2025, a decline of approximately 6.7%[28] - Total liabilities increased from $356,202,000 on January 3, 2025, to $358,588,000 on October 3, 2025, an increase of approximately 0.7%[28] - Cash and cash equivalents decreased from $258,901,000 on January 3, 2025, to $207,380,000 on October 3, 2025, a decline of approximately 19.9%[28] - Accounts receivable increased from $161,407,000 on January 3, 2025, to $181,996,000 on October 3, 2025, an increase of about 12.9%[28] - The company reported a decrease in accrued payroll and employee benefits from $119,285,000 to $108,922,000, a reduction of approximately 8.4%[28] - Total stockholders' equity decreased from $421,068,000 on January 3, 2025, to $402,861,000 on October 3, 2025, a decline of about 4.3%[28] Retained Earnings - Retained earnings rose to $658,788,000 on October 3, 2025, compared to $624,151,000 on January 3, 2025, marking an increase of about 5.5%[28]